Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer

S Noda, S Kanda - Expert Review of Respiratory Medicine, 2016 - Taylor & Francis
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have significantly
improved the survival of patients with advanced non-small cell lung cancer (NSCLC) …
被引用次数：12 相关文章

Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer.

S Noda, S Kanda - Expert Review of Respiratory Medicine, 2016 - europepmc.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have significantly
improved the survival of patients with advanced non-small cell lung cancer (NSCLC) …

Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer

S Noda, S Kanda - Expert review of respiratory medicine, 2016 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have significantly
improved the survival of patients with advanced non-small cell lung cancer (NSCLC) …